We drive bold smart solutions to extend longevity
Pathway Pharmaceuticals is a Hong Kong based personalized medicine company with a primary focus on oncology. The company provides solutions that help to make more informed decisions for cancer therapies selection for individual patients. The company’s core project is OncoFinder - a clinical decision-making support system, which uses Big Data bioinformatics, molecular analysis, and genetics to provide a complete analysis of a patient’s cancer to offer the most efficient personalized treatment.
OncoFinder is a system of personalized chemotherapy selection for people with cancer, based on the analysis of transcriptome data and intracellular signaling pathways of the patient. The system increases the effectiveness of chemotherapy assigned by the formula selection according to the individual characteristics of the patient's tumor, which reduces the toxic side effects of treatment.
First International Beauty Contest Judged by Artificial Intelligence
This is a deep-learned predictor of your age made with a deep neural network trained on hundreds of thousands anonymized human blood tests. Enter your data below and Aging.ai will guess your age and… gender
We applied Deep Learning technologies to recognize the intensity of your wrinkles and learned how to track the minute changes that occur during aging. We then developed a mobile app, which takes your picture, consider biomarkers of your face ageing and gives you objective picture of how your youthfulness changes in result of treatment.
VITAL (Validating Investment Tool for Advancing Life Sciences) enables us to screen hundreds of start-ups, private and public companies in the life science sector by evaluating market sizes, technology potential and company prospects.
Insilico Medicine Inc. is a bioinformatics company in the field of antiaging and personalized medicine. The company is committed to extension of human longevity by developing diseases and aging biomarkers, geroprotectors, and new tools for aging research using best practices from academia and IT. Insilico Medicine is an expert in drug repurposing, pathway activation analysis and deep learning tools and provides services to pharmaceutical, cosmetics, nutraceutical and personalized medicine companies.
Pharma.AI is a deep learning knowledge management system. Pharma.AI utilizes the latest advances in deep learning to improve computer analysis of massive multi-omics data and millions of tissue-specific pathway activation profiles obtained using proprietary methods developed by the company.
Canada Cancer and Aging Research Laboratories (CCARL) is a research and development company offering a personalized approach to cancer treatment. The company provides decision making systems in oncology based on knowledge of molecular signatures of various cancers, sex- and age-specificity of cancer response to treatment, and molecular and biochemical characteristics of regulation of various pro- and anti-cancer pathways.
Atlas Regeneration Inc. is a company dedicated to developing novel software platforms and algorithms for drug discovery relating to regenerative medicine and stem cell research.
Vision Genomics is a biotechnology-based company that focuses on research and development of therapeutics for age-related eye diseases. Our company undertakes an interdisciplinary approach using big data analysis to produce working solutions for age-related eye diseases.
The Biogerontology Research Foundation (the BGRF) is a UK-based charity organization. The objective of research conducted or funded by the BGRF is to produce effective cures or treatments for the diseases and frailty commonly associated with ageing in the human population. The foundation constantly makes open educational forums and supports the publication of scientific articles.
An international initiative aimed at challenging people to live longer. SuperCentenarians includes longevity advice and a $1 million prize to the first person to reach 123 years of age.
The Global Longevity Initiative aims to extend the period of healthy longevity to 100 years and beyond. The initiative is an international partnership of world leading universities, governmental agencies, biotech and pharmaceutical companies in order to create the science, technology, and commercialization hubs in the field of preventative and personalized medicine all around the globe.
Bioviva USA Inc is a cell and gene therapy company committed to extending human health-spans and providing regenerative medicine to the masses.BioViva is the first company in the world to treat a person with gene therapy to reverse biological aging, using a combination of two therapies. Testing and research on these therapies is continuing in BioViva’s affiliated labs worldwide.
July 07, 2016
June 17, 2016
June 18, 2016
April 22, 2016
April 19, 2016
April 03, 2014
December 9, 2014
June 4, 2014
November 6, 2014
December 16, 2015
April 21, 2015
March 15, 2015
February 24, 2015
June 19, 2015
BIOVIVA, GENE THERAPY AND BLOCKCHAIN MERGES IN RUSSIA
CEO of BioViva USA Inc, Elizabeth Parrish visited Moscow at the invitation of board member of the Blockchain Community, Alex Fork.
July 07, 2016